Why RedHill Biopharma Stock Is Getting Crushed Today
A clinical failure is sending shareholders to the exits this morning.
A clinical failure is sending shareholders to the exits this morning.
Grocery prices will rise by another three percent before the end of the year, according to one of America’s biggest supermarkets….
Several factors, including a potential rise in bond yields, supply-chain issues, and higher corporates taxes, could send the…
Investment platform Hargreaves Lansdown says that there’sΒ Β£246.5 billion languishing in accounts paying no interest at all.
DiaMedica (DMAC) is developing its recombinant KLK1 protein candidate, DM199 for treating patients who suffered an acute ischemic…
The Democrats’ proposed amnesty for migrants creates a hidden pipeline for U.S. employers to flood more cheap foreign graduates…
When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase…
Art is a risky investment, with estimated long-run returns, on average, below stocks. But investing in artworks may provide diversification…
The innovative health insurer presents an intriguing — but flawed — risk-to-reward profile.
Not every name Berkshire Hathaway holds is right for all investors, but any of these three picks would be at home in almost any…